RxSight (RXST) said Sunday it expects Q4 revenue of about $40.2 million, up roughly 41% from a year earlier.

Analysts polled by FactSet expect $40.4 million.

The company anticipates full-year 2024 revenue of $139.9 million. Analysts surveyed by FactSet expect $140 million.

For full-year 2025, RxSight expects revenue to come in between $185 million and $197 million. Analysts polled by FactSet expect $188 million.